NYSE:HAEMedical Equipment
Haemonetics’ Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE)
In late June 2026, Haemonetics Corporation (NYSE: HAE) was added to multiple Russell value-oriented and defensive benchmarks, including the Russell 2000 Value, Russell 2500 Value, Russell Small Cap Comp Value, Russell 3000 Value, and Russell 3000E Value indexes.
This broad inclusion across several Russell value and defensive indexes can increase passive ownership, deepen liquidity, and reinforce Haemonetics’ positioning as a value-tilted medtech name in institutional portfolios.
We’ll now...